Inventor · disambiguated record
Giovanni Monteleone
Also filed as: MONTELEONE GIOVANNI
25 granted patents·13 pending applications·327 citations·filing 2004–2021
97Inventor score
Top patents by PatentIndex Score
38 records- 0198US8648186B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2013·Granted Feb 11, 2014·45 cites·6 claims
- 0297US9605264B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2016·Granted Mar 28, 2017·13 cites·7 claims
- 0397US9518264B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2016·Granted Dec 13, 2016·13 cites·3 claims
- 0497US9382541B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2015·Granted Jul 5, 2016·15 cites·10 claims
- 0597US9279126B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2015·Granted Mar 8, 2016·16 cites·10 claims
- 0697US9096854B1Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2015·Granted Aug 4, 2015·19 cites·6 claims
- 0796US9006418B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2013·Granted Apr 14, 2015·19 cites·11 claims
- 0896US8907078B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2014·Granted Dec 9, 2014·20 cites·10 claims
- 0995US9951334B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2017·Granted Apr 24, 2018·8 cites·3 claims
- 1095US8106182B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldMONTELEONE GIOVANNI·Filed 2010·Granted Jan 31, 2012·24 cites·12 claims
- 1195US7807818B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldGIULIANI INT LTD·Filed 2008·Granted Oct 5, 2010·31 cites·12 claims
- 1294US10036022B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2016·Granted Jul 31, 2018·7 cites·6 claims
- 1392US8501806B2Methods for preventing or reducing colon carcinogenesisBARONI SERGIO·Filed 2009·Granted Aug 6, 2013·18 cites·17 claims
- 1492US7700757B2Antisense oligonucleotides (ODN) against Smad7 and uses in medical field thereofGIULIANI INTERNAITONAL LTD·Filed 2004·Granted Apr 20, 2010·31 cites·9 claims
- 1590US10473669B2Methods for treating inflammatory bowel diseaseNOGRA PHARMA LTD·Filed 2015·Granted Nov 12, 2019·4 cites·26 claims
- 1690US10006029B2Methods of treating colorectal cancerNOGRA PHARMA LTD·Filed 2014·Granted Jun 26, 2018·7 cites·13 claims
- 1789US10738309B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2018·Granted Aug 11, 2020·1 cites·3 claims
- 1889US10633660B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2018·Granted Apr 28, 2020·1 cites·7 claims
- 1988US10337004B2Methods and compositions for treating a subject with a SMAD7 antisense oligonucleotideNOGRA PHARMA LTD·Filed 2015·Granted Jul 2, 2019·6 cites·8 claims
- 2088US9791442B2Methods of monitoring responsiveness to anti-SMAD7 therapyMONTELEONE GIOVANNI·Filed 2012·Granted Oct 17, 2017·11 cites·24 claims
- 2187US10443056B2Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantationUNIV MIAMI·Filed 2018·Granted Oct 15, 2019·6 cites·14 claims
- 2287US10081809B2Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantationNOGRA PHARMA LTD·Filed 2013·Granted Sep 25, 2018·10 cites·26 claims
- 2385US12244987B2Microphone assemblyPEIKER ACUSTIC GMBH·Filed 2020·Granted Mar 4, 2025·2 cites·9 claims
- 2477US2020325480A1Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical FieldNOGRA PHARMA LTD·Filed 2020·Application pending·0 cites
- 2563US2007042985A1Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldMONTELEONE GIOVANNI·Filed 2006·Application pending·0 cites
- 2663US2012136043A1Antisense oligonucleotides (odn) against smad7 and uses thereof in medical fieldMONTELEONE GIOVANNI·Filed 2011·Application pending·0 cites
- 2757US2019100758A1Methods of Treating Colorectal CancerNOGRA PHARMA LTD·Filed 2018·Application pending·0 cites
- 2857US2023212582A1Compositions of smad7 antisense oligonucleotides (aso) and methods of using the sameNOGRA PHARMA LTD·Filed 2021·Application pending·0 cites
- 2957US2020239884A1Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantationUNIV MIAMI·Filed 2019·Application pending·0 cites
- 3054US2019338283A1Methods and compositions for treating a subject with a smad7 antisense oligonucleotideNOGRA PHARMA LTD·Filed 2019·Application pending·0 cites
- 3149US2018128829A1Methods for Monitoring Responsiveness to Anti-SMAD7 TherapyNOGRA PHARMA LTD·Filed 2017·Application pending·0 cites
- 3245US11787349B2Roof structure for a vehiclePEIKER ACUSTIC GMBH·Filed 2019·Granted Oct 17, 2023·0 cites·10 claims
- 3344US11162097B2Methods of treating intestinal fibrosis using SMAD7 inhibitionNOGRA PHARMA LTD·Filed 2017·Granted Nov 2, 2021·0 cites·12 claims
- 3444US2017233736A1Methods for dosing and monitoring smad7 antisense oligonucleotide treatment using biomarker levelsNOGRA PHARMA LTD·Filed 2015·Application pending·0 cites
- 3544US2021207143A1Methods of Treating Celiac Disease Using SMAD7 InhibitionNOGRA PHARMA LTD·Filed 2017·Application pending·0 cites
- 3643US2019328770A1Compositions of smad7 antisense oligonucleotide and methods of treating or preventing psoriasisNOGRA PHARMA LTD·Filed 2017·Application pending·0 cites
- 3743US2020237801A1Methods of using smad7 antisense oligonucleotides based on biomarker expressionNOGRA PHARMA LTD·Filed 2016·Application pending·0 cites
- 3842US2009214549A1Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical FieldMONTELEONE GIOVANNI·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →